ATE377427T1 - Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung - Google Patents
Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierungInfo
- Publication number
- ATE377427T1 ATE377427T1 AT05720656T AT05720656T ATE377427T1 AT E377427 T1 ATE377427 T1 AT E377427T1 AT 05720656 T AT05720656 T AT 05720656T AT 05720656 T AT05720656 T AT 05720656T AT E377427 T1 ATE377427 T1 AT E377427T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- hepatocyte growth
- induction
- promote
- vascular differentiation
- Prior art date
Links
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 title abstract 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 title abstract 2
- 230000004069 differentiation Effects 0.000 title abstract 2
- 230000006698 induction Effects 0.000 title abstract 2
- 230000002792 vascular Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000002798 bone marrow cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004066415 | 2004-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE377427T1 true ATE377427T1 (de) | 2007-11-15 |
Family
ID=34918334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05720656T ATE377427T1 (de) | 2004-03-09 | 2005-03-07 | Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070142279A1 (de) |
| EP (1) | EP1722811B1 (de) |
| JP (1) | JP2007528365A (de) |
| CN (1) | CN1929856B (de) |
| AT (1) | ATE377427T1 (de) |
| CA (1) | CA2557884C (de) |
| DE (1) | DE602005003211T2 (de) |
| ES (1) | ES2293553T3 (de) |
| HK (1) | HK1094529A1 (de) |
| WO (1) | WO2005084700A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007099711A1 (ja) * | 2006-02-28 | 2009-07-16 | 学校法人順天堂 | 分化誘導剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837676A (en) * | 1993-10-18 | 1998-11-17 | Long Island Jewish Medical Center | Use of scatter factor to enhance angiogenesis |
| IT1271088B (it) * | 1994-11-24 | 1997-05-26 | Dompe Spa | Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche |
| JPH08231416A (ja) * | 1995-02-24 | 1996-09-10 | Mitsubishi Chem Corp | 血栓症治療剤 |
| DE69838399T2 (de) * | 1997-12-03 | 2008-06-12 | Nakamura, Toshikazu | Präparation zur kontinuierlichen intravenösen verabreichung |
| AU5065599A (en) * | 1998-08-05 | 2000-02-28 | Sumitomo Pharmaceuticals Company, Limited | Preparations for the administration of hepatocyte growth factor |
| US20030171287A1 (en) * | 2000-06-27 | 2003-09-11 | Ryuichi Morishita | Medicinal compositions for angiogenic therapy |
| EP1415663B1 (de) * | 2001-07-18 | 2008-10-15 | MedGEL Corporation | Hgf-hydrogel-zubereitungen mit verzögerter freisetzung |
-
2005
- 2005-03-07 EP EP05720656A patent/EP1722811B1/de not_active Not-in-force
- 2005-03-07 JP JP2006527789A patent/JP2007528365A/ja active Pending
- 2005-03-07 DE DE602005003211T patent/DE602005003211T2/de active Active
- 2005-03-07 CN CN200580007431XA patent/CN1929856B/zh not_active Expired - Fee Related
- 2005-03-07 US US10/592,084 patent/US20070142279A1/en not_active Abandoned
- 2005-03-07 CA CA2557884A patent/CA2557884C/en not_active Expired - Fee Related
- 2005-03-07 AT AT05720656T patent/ATE377427T1/de not_active IP Right Cessation
- 2005-03-07 ES ES05720656T patent/ES2293553T3/es active Active
- 2005-03-07 WO PCT/JP2005/004385 patent/WO2005084700A1/en active IP Right Grant
-
2006
- 2006-12-13 HK HK06113707A patent/HK1094529A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070142279A1 (en) | 2007-06-21 |
| EP1722811A1 (de) | 2006-11-22 |
| ES2293553T3 (es) | 2008-03-16 |
| CN1929856A (zh) | 2007-03-14 |
| CN1929856B (zh) | 2010-11-10 |
| JP2007528365A (ja) | 2007-10-11 |
| DE602005003211T2 (de) | 2008-02-21 |
| EP1722811B1 (de) | 2007-11-07 |
| DE602005003211D1 (de) | 2007-12-20 |
| CA2557884C (en) | 2011-12-06 |
| WO2005084700A1 (en) | 2005-09-15 |
| HK1094529A1 (en) | 2007-04-04 |
| CA2557884A1 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fennema et al. | Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study | |
| Ezquer et al. | Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity | |
| Ahmed et al. | Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute | |
| Laschke et al. | Vascularization in tissue engineering: angiogenesis versus inosculation | |
| Wu et al. | Effects of hyperbaric oxygen on proliferation and differentiation of osteoblasts from human alveolar bone | |
| TW200633733A (en) | Biomaterials for guided tissue regeneration and drug delivery | |
| WO2001068811A3 (de) | Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial | |
| MX2009001323A (es) | Aposito solido para tratar tejido herido. | |
| NO20031999D0 (no) | Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| WO2005000245A3 (en) | Compositions and methods for increasing telomerase activity | |
| Li et al. | Autologous platelet-rich plasma promotes neurogenic differentiation of human adipose-derived stem cells in vitro | |
| Shou et al. | Enhancement of bone‐marrow‐derived mesenchymal stem cell angiogenic capacity by NPWT for a combinatorial therapy to promote wound healing with large defect | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| Oni et al. | Transdermal delivery of adipocyte-derived stem cells using a fractional ablative laser | |
| Creeper et al. | Effect of autologous and allogenic platelet‐rich plasma on human gingival fibroblast function | |
| Miramond et al. | Osteoinduction of biphasic calcium phosphate scaffolds in a nude mouse model | |
| JP2020506200A5 (de) | ||
| AU8180001A (en) | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells | |
| DK1405906T3 (da) | Schwann-celler stammende fra stromale knoglemarvsceller | |
| EA200900881A1 (ru) | Ингаляционные лекарственные формы связанных с полимерами бифосфонатов и способы их применения | |
| Levi et al. | Stem cells: update and impact on craniofacial surgery | |
| Boos et al. | Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model | |
| De Santis et al. | Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases | |
| ATE283714T1 (de) | Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |